| 17th Apr 2020 11:00 am |
RNS |
Changes to arrangements for AGM |
| 14th Apr 2020 7:00 am |
RNS |
Koselugo (selumetinib) approved in the US for NF1 |
| 14th Apr 2020 7:00 am |
RNS |
Tagrisso adjuvant trial overwhelmingly positive |
| 2nd Apr 2020 7:00 am |
RNS |
AstraZeneca divestment of Movantik completed |
| 1st Apr 2020 3:00 pm |
RNS |
Total Voting Rights |
| 31st Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 30th Mar 2020 7:01 am |
RNS |
Imfinzi approved in US for small cell lung cancer |
| 30th Mar 2020 7:00 am |
RNS |
Farxiga CKD trial early stop for positive efficacy |
| 26th Mar 2020 7:00 am |
RNS |
Lokelma approved in Japan for hyperkalaemia |
| 26th Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 24th Mar 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 24th Mar 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 24th Mar 2020 12:02 pm |
RNS |
Price Monitoring Extension |
| 23rd Mar 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Mar 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 23rd Mar 2020 12:08 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Mar 2020 12:03 pm |
RNS |
Price Monitoring Extension |
| 20th Mar 2020 10:20 am |
RNS |
Second Price Monitoring Extn |
| 20th Mar 2020 10:15 am |
RNS |
Price Monitoring Extension |
| 20th Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th Mar 2020 7:00 am |
RNS |
Lynparza granted orphan drug designation in Japan |
| 17th Mar 2020 7:00 am |
RNS |
Imfinzi confirmed overall survival in CASPIAN |
| 13th Mar 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 12th Mar 2020 11:00 am |
RNS |
Notice of AGM |
| 12th Mar 2020 7:00 am |
RNS |
Update on Phase III GY004 trial for cediranib |
| 10th Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2020 7:00 am |
RNS |
Update on Phase III DANUBE trial in bladder cancer |
| 4th Mar 2020 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 3rd Mar 2020 11:00 am |
RNS |
Annual Financial Report |
| 2nd Mar 2020 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Mar 2020 7:00 am |
RNS |
Divestment of hypertension medicines completed |
| 27th Feb 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 25th Feb 2020 7:00 am |
RNS |
AstraZeneca divests global rights to Movantik |
| 19th Feb 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2020 7:00 am |
RNS |
AZN: Full-year and Q4 2019 results |
| 3rd Feb 2020 3:00 pm |
RNS |
Total Voting Rights |
| 27th Jan 2020 7:00 am |
RNS |
Enhertu Phase II trial met primary endpoint |
| 27th Jan 2020 7:00 am |
RNS |
Brilinta met primary endpoint in stroke trial |
| 27th Jan 2020 7:00 am |
RNS |
AstraZeneca divests hypertension medicines |
| 27th Jan 2020 7:00 am |
RNS |
AstraZeneca to recover brazikumab (MEDI2070) |
